{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T19:28:23Z","timestamp":1776713303837,"version":"3.51.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.pneurobio.2012.05.012","type":"journal-article","created":{"date-parts":[[2012,6,3]],"date-time":"2012-06-03T03:41:52Z","timestamp":1338694912000},"page":"257-261","source":"Crossref","is-referenced-by-count":17,"title":["Developing treatment for spinal and bulbar muscular atrophy"],"prefix":"10.1016","volume":"99","author":[{"given":"Kenneth H.","family":"Fischbeck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2012.05.012_bib0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ana.21540","article-title":"Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy","volume":"65","author":"Banno","year":"2009","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0010","doi-asserted-by":"crossref","DOI":"10.1007\/s00441-012-1377-9","article-title":"Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA)","author":"Banno","year":"2012","journal-title":"Cell and Tissue Research"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0015","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1073\/pnas.0511256103","article-title":"Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases","volume":"103","author":"Bodner","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0020","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1523\/JNEUROSCI.0808-04.2004","article-title":"Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"24","author":"Chevalier-Larsen","year":"2004","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(10)70321-5","article-title":"Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial","volume":"10","author":"Fern\u00e1ndez-Rhodes","year":"2011","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0030","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","article-title":"Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"35","author":"Katsuno","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0035","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nm878","article-title":"Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"9","author":"Katsuno","year":"2003","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0040","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","article-title":"Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"9","author":"Katsuno","year":"2010","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"La Spada","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0050","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/mus.21399","article-title":"Standard and modified statistical MUNE evaluations in spinal-bulbar muscular atrophy","volume":"40","author":"Lehky","year":"2009","journal-title":"Muscle and Nerve"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0055","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/hmg\/11.17.1967","article-title":"Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor","volume":"11","author":"Lieberman","year":"2002","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0060","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.1073\/pnas.121173298","article-title":"Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor","volume":"98","author":"Lin","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0065","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","article-title":"CREB-binding protein sequestration by expanded polyglutamine","volume":"9","author":"McCampbell","year":"2000","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0070","doi-asserted-by":"crossref","first-page":"15179","DOI":"10.1073\/pnas.261400698","article-title":"Histone deacetylase inhibitors reduce polyglutamine toxicity","volume":"98","author":"McCampbell","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0075","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","article-title":"Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"13","author":"Minamiyama","year":"2004","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0080","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/hmg\/ddp115","article-title":"Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy","volume":"18","author":"Montie","year":"2009","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0085","doi-asserted-by":"crossref","first-page":"17425","DOI":"10.1523\/JNEUROSCI.3958-11.2011","article-title":"SIRT1 modulates aggregation and toxicity through deacetylation of the androgen receptor in cell models of SBMA","volume":"31","author":"Montie","year":"2011","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0090","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.neuron.2010.08.034","article-title":"Native functions of the androgen receptor are essential pathogenesis in a Drosophila model of spinobulbar muscular atrophy","volume":"67","author":"Nedelsky","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0095","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/hmg\/ddm109","article-title":"Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity","volume":"16","author":"Palazzolo","year":"2007","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuron.2009.07.019","article-title":"Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy","volume":"63","author":"Palazzolo","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0105","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/jnr.22389","article-title":"B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy","volume":"88","author":"Palazzolo","year":"2010","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0110","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nature05853","article-title":"HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the ubiquitin\u2013proteasome system","volume":"447","author":"Pandey","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0115","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.yfrne.2011.06.003","article-title":"Neurotoxic effects of androgens in spinal and bulbar muscular atrophy","volume":"32","author":"Parodi","year":"2011","journal-title":"Frontiers in Neuroendocrinology"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0120","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1365-2826.2003.01074.x","article-title":"Androgen 5-alpha-reductase type 2 is highly expressed and active in rat spinal cord motor neurones","volume":"15","author":"Pozzi","year":"2003","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/hmg\/ddn310","article-title":"Mitochondrial abnormalities in spinal and bulbar muscular atrophy","volume":"18","author":"Ranganathan","year":"2009","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.tips.2010.08.005","article-title":"Therapeutic approaches to spinal and bulbar muscular atrophy","volume":"31","author":"Ranganathan","year":"2010","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0135","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1093\/brain\/awp258","article-title":"Clinical features of spinal and bulbar muscular atrophy","volume":"132","author":"Rhodes","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0140","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1212\/WNL.59.5.770","article-title":"Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women","volume":"59","author":"Schmidt","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/79139","article-title":"Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription","volume":"26","author":"Shimohata","year":"2000","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0150","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0896-6273(02)00875-9","article-title":"Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila","volume":"35","author":"Takeyama","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0155","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1471-4914(02)02332-8","article-title":"Altered acetylation in polyglutamine disease: an opportunity for therapeutic intervention?","volume":"8","author":"Taylor","year":"2002","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0160","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm1298","article-title":"17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration","volume":"11","author":"Waza","year":"2005","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0165","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nm1547","article-title":"ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor","volume":"13","author":"Yang","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pneurobio.2012.05.012_bib0170","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1523\/JNEUROSCI.4072-08.2009","article-title":"Polyglutamine-expanded androgen receptor truncation fragments activate a Bax-dependent apoptotic cascade mediated by DP5\/Hrk","volume":"29","author":"Young","year":"2009","journal-title":"Journal of Neuroscience"}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008212000883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008212000883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T20:52:19Z","timestamp":1542919939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008212000883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0301008212000883"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2012.05.012","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}